Replies to post #384191 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Yep we found that out. Fortunately B shows promise in treating OM.

[bradfordbros]

You hit patients with Brilacidin the day they are diagnosed with COVID-19. Isn’t that what we are discovering now?

This trial may have put us on the mat but I believe we can beat the count. Down but not out is how I am feeling right now.

[snayeman]

But B is supposed to be more than just an antiviral! Possibly could show benefits in other areas of the disease! Doesn’t appear anything will help once a patient is to far gone, unless maybe a combo of things, maybe B can still be part of that combo

[frenchbroad]

I understand your thoughts Mr. Bradford. I thought there was some good chance the inflammatory action of Brilacidin could help these super sick people even more than killing the virus that remains in them. I think Mr. DeGrado believed this also.

But from the last days I also read many Ipix *experts* who write that Ipix designed the virus trial to last a long time and fail only so Mr. Ehrlich could receive a salary for more years. I read that Ipix knew they would have better success chance to give Brilacidin to people before they are super sick. This is so silly for me. The value of Mr. Erhlich's salary is a wee fraction of the value of his many shares if Ipix price is $10 or $2 or even $1. Anyone who thinks Mr. Ehrlich is more worried about his salary than the value of his shares is no expert for me.

The story of Brilacidin against the many new and old virus in the world is not finished but sure the new virus has won the first battle. And sure the story of Brilacidin itself has many chapters that remain in the book. Now we will see what Ipix can do next in this fight.